---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-184650"
form_type: "8-K"
ticker: "SNSE"
cik: "0001829802"
company_name: "Sensei Biotherapeutics, Inc."
filed_at: "2023-07-10T23:59:59+00:00"
generated_at: "2026-06-13T10:39:23.743547+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Sensei Biotherapeutics reports annual meeting results; all director nominees elected, Deloitte ratified

## Summary
- Bob Holmen elected with 12,245,867 votes for, 2,181,612 withheld.
- Kristian Humer elected with 11,914,421 votes for, 2,513,058 withheld.
- Deneen Vojta elected with 11,503,426 votes for, 2,924,053 withheld.
- Broker non-votes of 2,117,571 on each director proposal.
- Ratification of Deloitte & Touche as auditor passed with 16,096,264 for, 571 against, 448,215 abstained.

## SEC filing metadata
- accession: 0001193125-23-184650
- form_type: 8-K
- ticker: SNSE
- cik: 0001829802
- company_name: Sensei Biotherapeutics, Inc.
- filed_at: 2023-07-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829802/000119312523184650/0001193125-23-184650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829802/000119312523184650/d448825d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-184650
- JSON: https://secwatch.observer/filing/0001193125-23-184650.json
- Plain text: https://secwatch.observer/filing/0001193125-23-184650.txt

## Key facts
- Shareholder Votes
  Sensei Biotherapeutics, Inc. shareholders approved Election of three nominees to serve as directors on the Board of Directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified at the 2023-07-10 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-07-10
  source text: Proposal No. 1 : Election of three nominees to serve as directors on the Board of Directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows: Name Votes For Votes Withheld Broker Non-Votes Bob Holmen 12,245,867 2,181,612 2,117,571 Kristian Humer 11,914,421 2,513,058 2,117,571 Deneen Vojta 11,503,426 2,924,053 2,117,571 All nominees were elected.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829802/000119312523184650/0001193125-23-184650-index.htm
- Shareholder Votes
  Sensei Biotherapeutics, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-07-10 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-07-10
  source text: Proposal No. 2 : Ratification of the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. The votes were cast as follows: Votes For Votes Against Abstained 16,096,264 571 448,215
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829802/000119312523184650/0001193125-23-184650-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.